REMINDER: Our user survey closes on Friday, please submit your responses here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksFusion Antibody Share News (FAB)

Share Price Information for Fusion Antibody (FAB)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 3.40
Bid: 3.30
Ask: 3.50
Change: 0.00 (0.00%)
Spread: 0.20 (6.061%)
Open: 3.40
High: 3.40
Low: 3.40
Prev. Close: 3.40
FAB Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

TRADING UPDATES: Iofina interim profit doubles on higher iodine sales

Fri, 24th Sep 2021 11:01

(Alliance News) - The following is a round-up of updates by London-listed companies, issued on Friday and not separately reported by Alliance News:

----------

Iofina PLC - iodine production in US state of Oklahoma - For the six months ended June 30, pretax profit more than doubles to USD3.5 million from USD1.3 million a year before, on revenue which grew 27% year-on-year to USD19.9 million from USD15.7 million, driven by an increase in sales of iodine products, in spite of a drop in the price of raw iodine to USD33.45 per kilogram from USD35.49 a year prior. Iofina produces 249 metric tonnes of crystalline iodine, down 13% from 287 metric tonnes a year before. Looking ahead, company expects to meet its commercial expectations for 2021.

----------

Kingswood Holdings Ltd - London-based wealth manager - For the six months ended June 30, pretax loss narrows to GBP3.7 million from GBP6.1 million a year prior, on revenue which leapt year-on-year to GBP61.5 million from GBP8.3 million, following the consolidation of the group's US business after acquiring a 50% stake in Manhattan Harbor Capital in November 2020. Within the US business, EF Hutton Investment Banking revenue reaches GBP41.8 million on strong capital market activity.

----------

Fusion Antibodies PLC - Belfast-based therapeutic drug and diagnostic applications research organisation - Revenue growth has been consistent in its financial year-to-date and is in line with company expectations, while customer enquiries for all services remain robust. Financial year ends March 31, 2022. During the period, Fusion receives GBP150,000 milestone payment as a result of a humanised antibody project which was commercialised by a key client, the first payment gained by the company.

----------

Pembridge Resources PLC - London-based copper ores company - For the first half of 2021, pretax loss widens to USD2.5 million from USD993,000 a year before, due to a USD1.4 million revaluation of the Capstone Mining Corp liability. From subsidiary Minto Exploration PLC, 15,436 wet metric tonnes of concentrate was produced from the mine in Yukon, Canada, up from 13,795 tonnes, leading to higher mine revenue of USD48.3 million, up 90% from USD25.4 million.

----------

Panther Metals PLC - Isle of Man-based company focused on mineral exploration in Canada and Australia - For the six months ended June 30, pretax loss narrows to GBP88,465 from GBP388,126 a year prior, mainly due to a gain of GBP134,164 from a share-based payment credit from a charge of GBP135,806. Generates no revenue for the period, in line with a year before as none of the company's projects are in production yet. At Dotted Lake property in Canada, planned soil sampling programme commenced in mid-June.

----------

Argos Resources PLC - Falkland Islands-based exploration firm - For the six months ended June 30, loss from operations widened to USD200,000 from USD192,000 as a result of higher administrative costs. During the period, company noted a recovery in the oil industry with a rise in oil prices and increasing activity, but still hampered by continued Covid-19 restrictions. In response to this, Argos requested an extension to the term of licence PL001 to gain more time to recover from the downturn, which was granted to May 1, 2022.

----------

Nippon Active Value Fund PLC - Japan-focused investment firm - For the six months ended June 30, net asset value total return is 10.1%, outperforming the MSCI Japan Small Cap index, which returned 1.4%. NAV per share at the end of June is 123.20 pence, up 8.5% from 113.58p on December 30.

----------

By Dayo Laniyan; dayolaniyan@alliancenews.com

Copyright 2021 Alliance News Limited. All Rights Reserved.

More News
30 Apr 2024 19:54

EARNINGS AND TRADING: Software Circle & Beximco report higher revenue

(Alliance News) - The following is a round-up of earnings and trading updates by London-listed companies, issued on Tuesday and not separately reported by Alliance News:

Read more
15 Apr 2024 13:29

Fusion Antibodies inks commercial contract for OptiPhage library

(Alliance News) - Fusion Antibodies PLC on Monday said that it has signed a commercial contract to develop an OptiPhage library for a non-human antibody species.

Read more
27 Feb 2024 14:18

TRADING UPDATES: Sondrel wins USD23 million contract

(Alliance News) - The following is a round-up of updates by London-listed companies, issued on Tuesday and not separately reported by Alliance News:

Read more
27 Feb 2024 13:15

Fusion Antibodies gets first order under new services agreement

(Sharecast News) - Fusion Antibodies announced the receipt of its first purchase order under a master services agreement on Tuesday, which it agreed with a prominent diagnostics company on 14 February.

Read more
14 Feb 2024 12:52

Fusion Antibodies raises £1.38m as it seeks new customers

(Sharecast News) - Pre-clinical antibody specialist Fusion Antibodies announced a conditional fundraising of £1.38m before expenses on Wednesday, to help it target mo re industry conferences and customers and generate further supporting data.

Read more
14 Feb 2024 11:27

IN BRIEF: Fusion Antibodies raises GBP1.4 million via placing

Fusion Antibodies PLC - Belfast-based contract researcher, which provides discovery, design and optimisation services for therapeutic antibodies to the healthcare market - Conditionally raises GBP1.4 million before expenses via placing of 34.4 million shares at 4 pence each. The issue price represents a discount of 5.9% to Fusion's closing mid-market share price on Tuesday. Further, it intends to issue 1.5 million new shares to certain directors in lieu of or in satisfaction of salary and fees due to them and which shall be issued immediately following publication of its announcement. Also intends to grant a total of up to 3.8 million new share options to staff and senior management.

Read more
6 Feb 2024 11:48

Fusion Antibodies strikes follow-on research and development project

(Alliance News) - Fusion Antibodies PLC on Tuesday said it has won a follow-on project under a collaborative research and development agreement with an unnamed "US-based biotechnology company".

Read more
6 Feb 2024 10:05

AIM WINNERS & LOSERS: Beeks Financial Cloud is ahead of expectations

(Alliance News) - The following stocks are the leading risers and fallers on AIM in London on Tuesday.

Read more
1 Feb 2024 16:27

Fusion Antibodies confirms £0.28m tax credit

(Sharecast News) - Preclinical antibody discovery specialist Fusion Antibodies announced the successful receipt of a research and development tax credit from HMRC on Thursday.

Read more
1 Feb 2024 12:00

Fusion Antibodies gets tax credit from UK HMRC for OptiMAL platform

(Alliance News) - Fusion Antibodies PLC on Thursday announced the receipt of a research & development tax credit from UK HM Revenue & Customs for work performed on the development of its OptiMAL platform and other projects in bioinformatics.

Read more
4 Dec 2023 16:56

LONDON MARKET CLOSE: FTSE 100 slips as miners hold down index

(Alliance News) - Stock prices in London closed lower on Monday, with miners and oil firms holding down the FTSE 100 index.

Read more
4 Dec 2023 12:01

Fusion Antibodies revenue falls, losses widen in first half

(Sharecast News) - Contract research organisation Fusion Antibodies reported first-half revenue of £0.54m on Monday, down from £1.9m a year earlier.

Read more
4 Dec 2023 10:23

AIM WINNERS & LOSERS: Cornerstone FS to beat 2023 expectations

(Alliance News) - The following stocks are the leading risers and fallers on AIM in London on Monday.

Read more
4 Dec 2023 10:22

Fusion Antibodies shares fall with revenue despite "positive" outlook

(Alliance News) - Fusion Antibodies PLC on Monday reported a widened loss and reduced revenue for its latest half year, but said its growth prospects are "increasingly positive".

Read more
28 Nov 2023 12:09

Fusion Antibodies shares up on deal with US National Cancer Institute

(Alliance News) - Fusion Antibodies PLC on Tuesday said it has signed a collaboration agreement with the US National Cancer Institute to use its OptiMAL product to discover novel antibodies to treat certain targets.

Read more

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.